Texas Administrative Code
Title 26 - HEALTH AND HUMAN SERVICES
Part 1 - HEALTH AND HUMAN SERVICES COMMISSION
Chapter 354 - HEMOPHILIA ASSISTANCE PROGRAM
Section 354.7 - Benefits and Limitations
Current through Reg. 49, No. 38; September 20, 2024
An eligible client may receive either blood factor replacement products or insurance premium payment assistance in the same fiscal year, but not at the same time.
(1) Blood Factor Replacement Products. The program provides limited reimbursement to program providers for blood factor replacement products indicated for the treatment of hemophilia and prescribed to eligible clients for use in medical or dental facilities, or in the home.
(2) Program benefits for allowable products are limited to those prescribed by a physician and dispensed by a program provider.
(3) The program will pay for allowable products based upon:
(4) Eligible clients with private or group health insurance for which the program does not provide insurance premium payment assistance must exhaust all benefits prior to receiving program benefits for allowable products.
(5) Insurance Premium Payment Assistance. The program may assist eligible clients in obtaining public or private health insurance by providing insurance premium payment assistance if paying for such health insurance can reasonably be expected to be cost effective for the program.
(6) The program is payer of last resort. Applicants and currently eligible clients are no longer eligible when they become eligible for the CHIP, SSDI, or Medicaid.
(7) To meet budgetary limitations, the department may: